Thermo Fisher Scientific (TMO) Soars 3.17% Amid Pharma Layoffs

On April 23, 2025, Thermo Fisher Scientific Inc. (TMO) experienced a 3.17% rise in pre-market trading, reflecting a positive market sentiment towards the company.

The recent wave of layoffs across the pharmaceutical industry, including major players like Gilead Sciences, Novartis, Merck, and others, has been a significant development. These companies have announced substantial workforce reductions as part of their strategic adjustments and cost-cutting measures. Gilead Sciences, for instance, has been restructuring its operations, including the closure of its Kite Pharma facility in Philadelphia. Similarly, Novartis and Merck have announced layoffs in the United States, while other companies like Coherus Biosciences and Biogen have also implemented significant workforce reductions.

These layoffs are part of a broader trend in the pharmaceutical industry, where companies are focusing on optimizing their operations and reallocating resources to more promising areas. The industry is undergoing a shift towards greater efficiency and innovation, which may ultimately benefit companies like Thermo Fisher Scientific that are well-positioned to support these changes.